Hepatocellular carcinoma (HCC), the predominant primary liver tumor, remains one of the most lethal cancers worldwide, despite the advances in therapy in recent years. In addition to the traditional chemically and dietary-induced HCC models, a broad spectrum of novel preclinical tools have been generated following the advent of transgenic, transposon, organoid, and in silico technologies to overcome this gloomy scenario. These models have become rapidly robust preclinical instruments to unravel the molecular pathogenesis of liver cancer and establish new therapeutic approaches against this deadly disease. The present review article aims to summarize and discuss the commonly used preclinical models for HCC, evaluating their strengths and weaknesses.

Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges / Cigliano, Antonio; Liao, Weiting; Deiana, Giovanni A.; Rizzo, Davide; Chen, Xin; Calvisi, Diego F.. - In: BIOMEDICINES. - ISSN 2227-9059. - 12:7(2024). [10.3390/biomedicines12071624]

Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges

Cigliano, Antonio;Deiana, Giovanni A.;Rizzo, Davide;Calvisi, Diego F.
2024-01-01

Abstract

Hepatocellular carcinoma (HCC), the predominant primary liver tumor, remains one of the most lethal cancers worldwide, despite the advances in therapy in recent years. In addition to the traditional chemically and dietary-induced HCC models, a broad spectrum of novel preclinical tools have been generated following the advent of transgenic, transposon, organoid, and in silico technologies to overcome this gloomy scenario. These models have become rapidly robust preclinical instruments to unravel the molecular pathogenesis of liver cancer and establish new therapeutic approaches against this deadly disease. The present review article aims to summarize and discuss the commonly used preclinical models for HCC, evaluating their strengths and weaknesses.
2024
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges / Cigliano, Antonio; Liao, Weiting; Deiana, Giovanni A.; Rizzo, Davide; Chen, Xin; Calvisi, Diego F.. - In: BIOMEDICINES. - ISSN 2227-9059. - 12:7(2024). [10.3390/biomedicines12071624]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/342889
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact